Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Three signals on GLOBALFOUNDRIES converged on October 15 and 16. Each one individually tells a partial story. Together, they point to a market positioning itself for a significant move into the November 3 earnings date.
The clearest signal is in the options market, and it marks a reversal from the note published two days ago. On October 14, the previous article noted that the call-heavy drift since early September had stalled, with the put/call ratio edging back toward neutral. That stall has now broken decisively in the bullish direction.
The PCR dropped to 0.82 on October 15. The 20-day mean is 0.95. That gap represents a z-score of -2.46, meaning call demand relative to puts is 2.5 standard deviations more aggressive than its recent norm. As recently as late August, the ratio was running above 1.20. The six-week directional trend that had appeared to pause has accelerated instead.
This is now the lowest PCR reading since late August. With earnings 18 days out, options traders are not hedging, they are reaching for upside.
Separately, ORTEX's retail attention measure jumped to 2.9 standard deviations above its own 90-day average as of October 15. The signal combines daily English Wikipedia article views and distinct ORTEX stock-page visitors, each measured on a log scale. It captures engagement, not revenue, and carries no lead status against GFS financial figures. What it does capture is unusual public interest arriving at the same moment options traders are making their most aggressive call bets since the summer.
A retail attention spike of this magnitude on a $48 semiconductor foundry stock is not routine. It suggests the options move is not purely institutional.
Short sellers, meanwhile, continued to pull back. Shares short fell 11.5% in the week to October 14, reaching 1.23% of free float, the lowest level since early September. That reverses a build that ran from roughly 5.3 million shares in late August to a peak near 7.8 million in early October. The borrow market is wide open: availability stands at 1,312%, meaning roughly 13 shares are available to borrow for every one currently shorted. Cost to borrow edged up 12% over the week to 0.44%, still exceptionally low.
At 1.23% of float, short interest is not a primary driver here. Its relevance is the direction: the people who built that September short position are now leaving ahead of the print.
The analyst consensus remains "hold," with a mean target of $74.68 against a current price of $48.76, implying significant upside if the bulls are proved right. TD Cowen reiterated Buy at $75 and Wedbush reiterated Neutral at $72 on October 15, leaving the street split. The November 3 print is the resolution point. Between now and then, the convergence of a surging PCR, a short-seller exit, and an unusual retail attention spike makes GFS one of the more actively watched names in the semiconductor space.
Data summary:
See the live data behind this article on ORTEX.
Open GFS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
